Compound ID | 1864
Synonym(s): S-4661
Class: Beta-lactam (carbapenem)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Carbapenems bind to all PBPs, with PBP2 and PBP4 as the highest-affinity targets.Carbapenems have a very broad spectrum incl. non-fermenters and are not hydrolysed by most beta-lactamases with exception of carbapenemases |
Description: | Semisynthetic, derived from thienamycin. Similar to meropenem |
Institute where first reported: | Shionogi Inc |
Year first mentioned: | 2003 |
Highest developmental phase: | Approved by FDA in 2007 |
Development status: | Discontinued |
Reason Dropped: | In treating patients with pneumoniae, doripenem showed increased risk of death and lower clinical cure rates compared to imipenem and cilastatin for injection |
Chemical structure(s): | |
Canonical SMILES: | C[C@@H]1[C@@H]2[C@@H]([C@@H](C)O)C(=O)N2C(=C1S[C@H]3C[C@@H](CNS(=O)(=O)N)NC3)C(=O)O |
Isomeric SMILES: | C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O |
InChI: | InChI=1S/C15H24N4O6S2/c1-6-11-10(7(2)20)14(21)19(11)12(15(22)23)13(6)26-9-3-8(17-5-9)4-18-27(16,24)25/h6-11,17-18,20H,3-5H2,1-2H3,(H,22,23)(H2,16,24,25)/t6-,7-,8+,9+,10-,11-/m1/s1 |
InChI Key: | AVAACINZEOAHHE-VFZPANTDSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/73303 |
External links: | |
Guide to Pharmacology: | doripenem |
Main Source: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730083/ |
Citation: | https://pubs.acs.org/doi/10.1021/op034088n |